Aptamers News and Research

RSS
Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion signs definitive asset purchase agreement to acquire EGEN

Researchers find new technique to detect just a handful of lurking tumor cells

Researchers find new technique to detect just a handful of lurking tumor cells

NOXXON Pharma reports interim data from two phase IIa studies of anti-CXCL12/SDF-1 Spiegelmer NOX-A12

NOXXON Pharma reports interim data from two phase IIa studies of anti-CXCL12/SDF-1 Spiegelmer NOX-A12

Chemists develop new method for parallel protein analysis

Chemists develop new method for parallel protein analysis

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

NOXXON completes patient recruitment of NOX-E36 Phase IIa trial for treatment of diabetic nephropathy

Researchers develop RNA aptamers that inhibit HCV replication

Researchers develop RNA aptamers that inhibit HCV replication

Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

Experimental drug can reduce breast-cancer aggressiveness, restore drug-sensitivity

New apatamer can boost therapeutic effect of cell-based vaccines

New apatamer can boost therapeutic effect of cell-based vaccines

TU Darmstadt’s biosensor can diagnose African sleeping sickness before it breaks out

TU Darmstadt’s biosensor can diagnose African sleeping sickness before it breaks out

BioResearch Open Access explores Cell-SELEX technology

BioResearch Open Access explores Cell-SELEX technology

Researchers use DNA molecules to stimulate repair of nerve coatings that mimic MS

Researchers use DNA molecules to stimulate repair of nerve coatings that mimic MS

NEC, SomaLogic release professional software tool

NEC, SomaLogic release professional software tool

SomaLogic, HUNT Biosciences partner to advance clinical use of cardiovascular biomarkers

SomaLogic, HUNT Biosciences partner to advance clinical use of cardiovascular biomarkers

Gold nanostars can deliver drug directly to cancer cell nucleus

Gold nanostars can deliver drug directly to cancer cell nucleus

DNA ‘nanorobot’  effectively targets cancer leaving healthy cells untouched: Study

DNA ‘nanorobot’ effectively targets cancer leaving healthy cells untouched: Study

SomaLogic to receive TB biomarkers grant from Gates Foundation

SomaLogic to receive TB biomarkers grant from Gates Foundation

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

SomaLogic, Novartis enter multi-year research agreement

SomaLogic, Novartis enter multi-year research agreement

Low-cost, portable technique can detect specific proteins in human blood

Low-cost, portable technique can detect specific proteins in human blood

Regado's REG1 system Phase 2b trial results presented at i2 Summit

Regado's REG1 system Phase 2b trial results presented at i2 Summit